Jaguar Health Inc. (NASDAQ:JAGX) went down by -9.49% from its latest closing price compared to the recent 1-year high of $4.47. The company’s stock price has collected 2.14% of gains in the last five trading sessions. Press Release reported on 02/19/21 that Jaguar Health Announces Commitment to Move Forward with Exclusive Relationship with the Planned Dragon SPAC, which is Pursuing Listing on AIM Italia and Plans to Target Napo EU
Is It Worth Investing in Jaguar Health Inc. (NASDAQ :JAGX) Right Now?
Plus, the 36-month beta value for JAGX is at 1.61. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Jaguar Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $5.00. JAGX currently public float of 65.17M and currently shorts hold a 9.13% ratio of that float. Today, the average trading volume of JAGX was 64.65M shares.
JAGX’s Market Performance
JAGX stocks went up by 2.14% for the week, with a monthly drop of -2.05% and a quarterly performance of 1405.26%, while its annual performance rate touched 307.12%. The volatility ratio for the week stands at 10.15% while the volatility levels for the past 30 days are set at 12.55% for Jaguar Health Inc.. The simple moving average for the period of the last 20 days is -2.70% for JAGX stocks with a simple moving average of 237.39% for the last 200 days.
Analysts’ Opinion of JAGX
Many brokerage firms have already submitted their reports for JAGX stocks, with Rodman & Renshaw repeating the rating for JAGX by listing it as a “Buy.” The predicted price for JAGX in the upcoming period, according to Rodman & Renshaw is $2 based on the research report published on July 11th of the previous year 2017.
JAGX Trading at 37.65% from the 50-Day Moving Average
After a stumble in the market that brought JAGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.02% of loss for the given period.
Volatility was left at 12.55%, however, over the last 30 days, the volatility rate increased by 10.15%, as shares sank -8.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +605.48% upper at present.
During the last 5 trading sessions, JAGX rose by +2.14%, which changed the moving average for the period of 200-days by +431.20% in comparison to the 20-day moving average, which settled at $2.93. In addition, Jaguar Health Inc. saw 250.92% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for JAGX
Current profitability levels for the company are sitting at:
- -420.75 for the present operating margin
- +33.93 for the gross margin
The net margin for Jaguar Health Inc. stands at -667.32. The total capital return value is set at -82.93, while invested capital returns managed to touch -217.73. Equity return is now at value -853.40, with -98.40 for asset returns.
Based on Jaguar Health Inc. (JAGX), the company’s capital structure generated 36.78 points at debt to equity in total, while total debt to capital is 26.89. Total debt to assets is 20.78, with long-term debt to equity ratio resting at 5.02. Finally, the long-term debt to capital ratio is 1.60.
When we switch over and look at the enterprise to sales, we see a ratio of 3.34, with the company’s debt to enterprise value settled at 0.39. The receivables turnover for the company is 4.28 and the total asset turnover is 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.62.